Fig. 6From: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysisForest plots of objective response rate (ORR). Forest plots of ORR for Nivolumab alone or in combination with Ipilimumab; CI, confidence intervalBack to article page